Pages that link to "Q71978453"

The following pages link to Comparison of the Neurochemical and Behavioral Effects Resulting from the Inhibition of Kynurenine Hydroxylase and/or Kynureninase (Q71978453):

Displaying 45 items.

• Cloning and recombinant expression of rat and human kynureninase (Q24309216) (← links)
• Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System (Q26796667) (← links)
• Kynurenines in the mammalian brain: when physiology meets pathology (Q27003296) (← links)
• Changing the face of kynurenines and neurotoxicity: therapeutic considerations (Q28085041) (← links)
• Targeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN (Q29306917) (← links)
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance (Q32148941) (← links)
• Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects (Q33583816) (← links)
• Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites (Q33709247) (← links)
• Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection (Q33877260) (← links)
• Inhibitors of the kynurenine pathway (Q33887356) (← links)
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy States (Q34633683) (← links)
• Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring (Q35202246) (← links)
• Minocycline effect on life and health span of Drosophila melanogaster (Q36409142) (← links)
• Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients (Q36482308) (← links)
• Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. (Q36490729) (← links)
• The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression (Q37186953) (← links)
• The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders (Q37318862) (← links)
• α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions (Q37946405) (← links)
• Kynurenines and Glutamate: Multiple Links and Therapeutic Implications (Q38861843) (← links)
• Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. (Q39185463) (← links)
• Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis (Q39445647) (← links)
• Excitotoxicity of quinolinic acid: modulation by endogenous antagonists (Q40314127) (← links)
• Studies on the Pharmacological Properties of Oxindole (2-Hydroxyindole) and 5-Hydroxyindole: Are They Involved in Hepatic Encephalopathy? (Q41586783) (← links)
• Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors (Q41808430) (← links)
• Electrophysiological studies on oxindole, a neurodepressant tryptophan metabolite. (Q41902069) (← links)
• Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro (Q42806464) (← links)
• Role of kynurenines in the neurotoxic actions of kainic acid (Q43263753) (← links)
• Prenatal exposure to methyl mercury in rats: focus on changes in kynurenine pathway. (Q43685897) (← links)
• Increased cortical kynurenate content in schizophrenia (Q43766055) (← links)
• Diclofenac increases the accumulation of kynurenate following tryptophan pretreatment in the rat: a possible factor contributing to its antihyperalgesic effect (Q44808701) (← links)
• Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase (Q48127305) (← links)
• Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain (Q48389890) (← links)
• Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry (Q48402823) (← links)
• Kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? (Q53663339) (← links)
• Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway (Q60907801) (← links)
• Tryptophan Metabolism: A Versatile Area Providing Multiple Targets for Pharmacological Intervention (Q64259219) (← links)
• Investigation of the role of 3-hydroxyanthranilic acid in the degradation of lignin by white-rot fungus Pycnoporus cinnabarinus (Q73589838) (← links)
• Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo (Q73755539) (← links)
• Formation of endogenous glutamatergic receptors antagonist kynurenic acid--differences between cortical and spinal cord slices (Q74340371) (← links)
• Set-up and validation of an adsorptive stripping voltammetric method for kynurenic acid determination in human urine (Q77719903) (← links)
• S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase (Q77744202) (← links)
• The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound (Q77993755) (← links)
• Tryptophan in alcoholism treatment II: inhibition of the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevation of blood acetaldehyde concentration and induction of aversion to alcohol by combined administration of tryptophan and (Q84900604) (← links)
• Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia (Q92802677) (← links)
• The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal (Q93134464) (← links)